The detection and quantitation of inflammation in the central nervous system during experimental allergic encephalomyelitis using the radiopharmaceutical 99mTc-RP128

Journal of Neuroscience Methods

Volumn 98, Issue 1, 2000, Pages 83-90

  Paul, Carolyn ^a   Peers, Susan H ^b   Woodhouse, Lesley E ^c   Thornback, John R ^b   Goodbody, Anne E ^d   Bolton, Christopher ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

^b Resolution Pharmaceuticals Inc   (Canada)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

^d Bayer Inc   (Canada)

Author keywords

99mTc RP128; Allergic encephalomyelitis; Central nervous system; Inflammation; Radiopharmaceutical

Indexed keywords

RADIOPHARMACEUTICAL AGENT; RP 128; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EXPERIMENTAL MODEL; INFLAMMATORY DISEASE; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DEXAMETHASONE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLUCOCORTICOIDS; MALE; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; RATS; RATS, INBRED LEW;

EID: 0034658357     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(00)00201-6     Document Type: Article

References (44)

1. Bastianello S, Pozzilli C., Bernardi S., Bozzao L., Fantozzi L.M., Buttinelli C., Fieschi C. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology. 40:1990;591-595.
2. Bauer J., Ruuls S.R., Huitinga I., Dijkstra C.D. The role of macrophage subpopulations in autoimmune disease of the central nervous system. Histochem. J. 28:1996;83-97.
3. Becker W., Palestro C.J., Winship J., Feld T., Pinsky C.M., Wolf F., Goldenberg D.M. Rapid imaging of infections with a monoclonal antibody fragment (LeukoScan). Clin. Orthop. 329:1996;263-272.
4. Bester M.J., Van Heerden P.D., Klopper J.F., Wasserman H.J., Rubow S., de Klerk F. Imaging infection and inflammation in an African environment: Comparison of 99Tcm-HMPAO-labelled leukocytes and 67Ga-citrate. Nucl. Med. Commun. 16:1995;599-607.
5. Bolton C., Gordon D., Turk J.L. Prostaglandin and thromboxane levels in central nervous system tissues from rats during the induction and development of experimental allergic encephalomyelitis (EAE). Immunopharmacology. 7:1984;101-107.
6. Bolton C., Paul C. MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis. J. Pharmacol. Exp. Ther. 282:1997;397-402.
7. Boxon I., Ballinger J.R. Nuclear medicine detection of inflammation and infection. Curr. Opin. Radiol. 3:1991;840-850.
8. Caveliers V., Goodbody A., Tran L., Bossuyt A., Thornback J. Human dosimetry of Tc99m-RP128, a potential inflammation imaging agent. Eur. J. Nucl. Med. 23:1996;1131.
9. Claudio L., Kress Y., Factor J., Brosnan C.F. Mechanisms of edema formation in experimental autoimmune encephalomyelitis: the contribution of inflammatory cells. Am. J. Pathol. 137:1990;1033-1045.
10. Claudio L., Raine C.S., Brosnan C.F. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol. 90:1995;228-238.
11. Datz F.L. Indium-111-labelled leukocytes for the detection of infection: Current status. Semin. Nucl. Med. 24:1994;92-109.
12. Datz F.L., Morton K.A. Radionuclide detection of occult infection: current strategies. Cancer Invest. 9:1991;691-698.
13. Datz F.L., Castronovo F.P., Christian P.E., Anderson C.E., Crebs K., Morton K.A., Rauh D.A. Biodistribution and dosimetry of indium-111-polyclonal IgG in normal subjects. J. Nucl. Med. 36:1995;2372-2379.
14. Fischman A.J., Babich J.W., Strauss H.W. A ticket to ride: peptide radiopharmaceuticals. J. Nucl. Med. 34:1993;2253-2263.
15. Fridkin M., Najjar V.A. Tuftsin: its chemistry, biology, and clinical potential. Crit. Rev. Biochem. Mol. Biol. 24:1989;1-40.
16. Gay D., Esiri M. Blood-brain barrier damage in acute multiple sclerosis plaques. Brain. 114:1991;557-572.
17. Greig M.E., Gibbons A.J., Elliott G.A. A comparison of the effects of melengestrol acetate and hydrocortisone acetate on experimental allergic encephalomyelitis in rats. J. Pharmacol. Exp. Ther. 173:1970;85-93.
18. Grossman R.I., Lisak R.P., Macchi P.J., Joseph P.M. MR of acute experimental allergic encephalomyelitis. Am. J. Nucl. Res. 8:1987;1045-1048.
19. Grossman R.I., Braffman B.H., Brorson J.R., Goldberg H.I., Silberberg D.H., Gonzalez-Scarano F. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology. 169:1988;117-122.
20. Hawkins C.P., Munro P.M.G., Mackenzie F., Kesselring J., Tofts P.S., du Boulay E.P.G.H., Landon D.N., McDonald W.I. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain. 113:1990;365-378.
21. Hedley-Whyte E.T., Hsu D.W. Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann. Neurol. 19:1986;373-377.
22. Iles D.L., Goodbody A.E., Cockeram A., Beaudin D., Beyea D., Reid J., Fitzpatrick J., Peers S.H., Eshima L., Thornback J.R. A pilot phase II clinical study on imaging inflammatory lesions in patients with Crohn's disease using Tc-99m RP128. J. Nucl. Med. 39:1998;271.
23. Koh C.-S., Gausas J., Paterson P.Y. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis. J. Neuroimmunol. 38:1992;85-94.
24. Leibowitz S., Kennedy L. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis. Immunology. 22:1972;859-869.
25. Long J.B., Holaday J.W. Blood-brain barrier: endogenous modulation by adrenal-cortical function. Science. 227:1985;1580-1582.
26. MacPhee I.A.M., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169:1989;431-445.
27. McConahey P.J., Dixon F.J. Radioiodination of proteins by the use of the chloramine-T method. vam Vunakis H., Langone J.J. Methods in Enzymology. 1980;210-213 Academic Press, London.
28. Miller D.H., McDonald W.I. Neuroimaging in multiple sclerosis. Clin. Neurosci. 2:1994;215-224.
29. Moncayo R., Baldissera I., Decristoforo C., Kendler D., Donnemiller E. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide. Thyroid. 7:1997;21-29.
30. Morrissey S.P., Stodal H., Zettl U., Simonis C., Jung S., Kiefer R., Lassmann H., Hartung H.-P., Haase A., Toyka K.V. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis: quantification of inflammation and oedema. Brain. 119:1996;239-248.
31. Newcombe J., Hawkins C.P., Henderson C.L., Patel H.A., Woodroofe M.N., Hayes G.M., Cuzner M.L., MacManus D., du Boulay E.P.G.H., McDonald W.I. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain. 114:1991;1013-1023.
32. Nijhof M.W., Oyen W.J., van Kampen A., Claessens R.A., van der Meer J.W., Corstens F.H. Evaluation of infections of the locomotor system with indium-111-labelled human IgG scintigraphy. J. Nucl. Med. 38:1997;1300-1305.
33. Ormerod I.E., Miller D.H., McDonald W.I., du Boulay E.P., Rudge P., Kendall B.E., Moseley I.F., Johnson G., Tofts P.S., Halliday A.M., Bronstein A.M., Scaravilli F., Harding A.E., Barnes D., Zilkha K.J. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain. 110:1987;1579-1616.
34. Paul C., Bolton C. Pharmacological manipulation of blood-brain barrier (BBB) breakdown during recovery from experimental allergic encephalomyelitis (EAE) in the Lewis rat. J. Physiol. 480P:1994;11-12.
35. Paul C., Bolton C. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int. J. Immunopharmacol. 17:1995;497-503.
36. Peers S.H., Tran L., Eriksson S., Ballinger J., Goodbody A.E. Imaging a model of colitis with RP128, a Tc-99m-chelated tuftsin antagonist. J. Nucl. Med. 36:1995;272.
37. Peers S.H., Tesic M., Fitzgerald J., Lu L., Lau F., Ho B., Tran L.L., Roberts S., Thornback J.R., Goodbody A.E. Stability of Tc-99m RP128 in vivo and in vitro. J. Nucl. Med. 38:1997;189-190.
38. Peters A.M. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin. Nucl. Med. 24:1994;110-127.
39. Pollak A., Goodbody A.E., Ballinger J.R., Duncan G.S., Tran L.L., Dunn-Dufault R., Meghji K., Andrey T.W. Imaging inflammation with 99Tcm-labelled chemotactic peptides: analogues with reduced neutropenia. Nucl. Med. Commun. 17:1996;132-139.
40. Polman C.H., Dijkstra C.D., Sminia T., Koetsier J.C. Immunohistological analysis of macrophages in the central nervous system of Lewis rats with acute experimental allergic encephalomyelitis. J. Neuroimmunol. 11:1986;215-222.
41. Pons F., Sanmarti R., Herranz R., Collado A., Piera C., Vidal-Sicart S., Munoz-Gomez J., Setoain J. Scintigraphic evaluation of the severity of inflammation of the joints with 99TCm-HIG in rheumatoid arthritis. Nucl. Med. Commun. 17:1996;523-528.
42. Thakur M.L., Marcus C.S., Henneman P., Butler J., Sinow R., Diggles L., Minami C., Mason G., Klein S., Rhodes B. Imaging inflammatory diseases with neutrophil-specific technetium-99m-labelled monoclonal antibody anti-SSEA-1. J. Nucl. Med. 37:1996;1789-1795.
43. Weller R.O. Pathology of multiple sclerosis. Matthews W.B. McAlpines Multiple Sclerosis. 1985;301-343 Churchill Livingstone, London.
44. Willoughby E.W., Grochowski E., Li D.K.B., Oger J., Kastrukoff L.F., Paty D.W. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients. Ann. Neurol. 25:1989;43-49.